We invest significant resources in the development of new products. Our domain is generic drugs, thanks to which we enable access to modern therapies for a wide group of patients. We conduct our own research and development, and we cooperate with universities and research institutes in Poland and abroad. We develop products in new, very advanced areas: ophthalmology, spirometry (asthma) and injectables (long-acting injections for the treatment of schizophrenia).
Polpharma invests significant resources in the development of new products and innovative solutions